Thanks to ROS1ders’ Partner Turning Point Therapeutics

Jean Cui (right) and Miriam Cruz (left) of Turning Point Therapeutics
with Janet Freeman-Daily of The ROS1ders

Dear Turning Point Therapeutics,

Thank you so much for inviting me to speak to your employees about my personal ROS1 lung cancer story and the work of The ROS1ders. I truly appreciate your willingness to consider a patient perspective on ways to improve awareness of and access to biomarker testing and clinical trials for cancer patients.

A HUGE thank you for your generous gift to our ROS1ders fundraiser at the nonprofit GO2 Foundation for Lung Cancer!  Your gift will help fund patient-driven research projects like our ROS1 Cancer Model Project, which has already generated four new ROS1 cell lines and three publications for our rare disease.

I look forward to a long and productive partnership as we work together to improve outcomes for all ROS1+ cancers.

Sincerely,

Janet Freeman-Daily
Cofounder, The ROS1ders